Bupivacaine liposome is one of 90 small molecule programs targeting Rib Fracture. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
275 competitors in Total Knee Arthroplasty
Bupivacaine liposome
Cymbalta
Lyrica
Xarelto
Precedex
Sufenta
EXPAREL
Xylocaine
Epsom Salt
Zanaflex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details